Related references
Note: Only part of the references are listed.Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes
Siroon Bekkering et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress
Xiao-Zhen Zhuo et al.
APOPTOSIS (2013)
Endothelial Dysfunction in Rheumatoid Arthritis The Role of Monocyte Chemotactic Protein-1-Induced Protein
Ming He et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Uremic Serum and Solutes Increase Post-Vascular Interventional Thrombotic Risk Through Altered Stability of Smooth Muscle Cell Tissue Factor
Vipul C. Chitalia et al.
CIRCULATION (2013)
Enhanced Atherosclerosis in TIPE2-Deficient Mice Is Associated with Increased Macrophage Responses to Oxidized Low-Density Lipoprotein
Yunwei Lou et al.
JOURNAL OF IMMUNOLOGY (2013)
Cellular Effects of Everolimus and Sirolimus on Podocytes
Sandra Mueller-Krebs et al.
PLOS ONE (2013)
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Ken Inoki et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
MicroRNA-34a regulates the longevity-associated protein SIRT I in coronary artery disease: effect of statins on SIRT I and microRNA-34a expression
Tsuyoshi Tabuchi et al.
CLINICAL SCIENCE (2012)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: Effect of statins on let-7i and Toll-like receptor 4 signal
Mamoru Satoh et al.
IMMUNOBIOLOGY (2012)
Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia
Robert J. Henning et al.
TRANSLATIONAL RESEARCH (2012)
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease
Giampaolo Niccoli et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
Toll-like receptor 4 is up-regulated by mTOR activation during THP-1 macrophage foam cells formation
Miao Yu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
The double-faced metabolic and inflammatory effects of standard drug therapy in patients after percutaneous treatment with drug-eluting stent
Yue Wu et al.
ATHEROSCLEROSIS (2011)
Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome
Zhao Zhao et al.
ATHEROSCLEROSIS (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants
Alexander K. Tsai et al.
TRANSLATIONAL RESEARCH (2011)
mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy
Xiaoxiao Song et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Immune and Inflammatory Mechanisms of Atherosclerosis
Elena Galkina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages
Ting Chen et al.
CARDIOVASCULAR RESEARCH (2009)
Everolimus Inhibits Monocyte/Macrophage Migration in Vitro and Their Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits
Roberta Baetta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma
Chia-Jui Yen et al.
CANCER RESEARCH (2008)
Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappa B
LF Costa et al.
BLOOD (2006)
Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice - Inhibitory effect on monocyte chemotaxis
R Pakala et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-κB activation in endothelial cells
M Minhajuddin et al.
JOURNAL OF IMMUNOLOGY (2005)
Circulating mononuclear cells in the obese are in a proinflammatory state
H Ghanim et al.
CIRCULATION (2004)
Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 (Kip1)-independent pathway
C Castro et al.
ATHEROSCLEROSIS (2004)
Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice
MM Elloso et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells
W Dichtl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells -: The potential role of transcription factor NF-κB
DY Li et al.
CIRCULATION (2000)
The evolving role of statins in the management of atherosclerosis
CJ Vaughan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
